Trends of Exposure to Acrylamide as Measured by Urinary Biomarkers Levels within the HBM4EU Biomonitoring Aligned Studies (2000–2021)

MLA

Michael Poteser, et al. Trends of Exposure to Acrylamide as Measured by Urinary Biomarkers Levels within the HBM4EU Biomonitoring Aligned Studies (2000–2021). Jan. 2022. EBSCOhost, https://doi.org/10.3390/toxics10080443.

APA

Michael Poteser, Federica Laguzzi, Thomas Schettgen, Nina Vogel, Till Weber, Aline Murawski, Phillipp Schmidt, Maria Rüther, Marike Kolossa-Gehring, Sónia Namorado, An Van Nieuwenhuyse, Brice Appenzeller, Edda Dufthaksdóttir, Kristín Olafsdóttir, Line Småstuen Haug, Cathrine Thomsen, Fabio Barbone, Valentina Rosolen, Loïc Rambaud, … Hanns Moshammer. (2022). Trends of Exposure to Acrylamide as Measured by Urinary Biomarkers Levels within the HBM4EU Biomonitoring Aligned Studies (2000–2021). https://doi.org/10.3390/toxics10080443

Chicago

Michael Poteser, Federica Laguzzi, Thomas Schettgen, Nina Vogel, Till Weber, Aline Murawski, Phillipp Schmidt, et al. 2022. “Trends of Exposure to Acrylamide as Measured by Urinary Biomarkers Levels within the HBM4EU Biomonitoring Aligned Studies (2000–2021),” January. doi:10.3390/toxics10080443.